Sort
21,453 grants matching “tuberculosis”
Nanostructured in vitro TB latency model
$187,500Graham S Timmins · University Of New Mexico · R21 · FY2009 · AI
Drug Target Validation in Trypanosoma cruzi
$187,500Roberto Docampo · University Of Georgia · R21 · FY2019 · AI
Overcoming Isoniazid Resistance in Tuberculosis with New Chemical Entitites
$187,500Graham S Timmins · Spinceutica, Inc. · R43 · FY2018 · PS
Mycobacterium tuberculosis lipoarabinomannan metabolism within human macrophages
$187,500Larry S. Schlesinger · Ohio State University · R21 · FY2007 · AI
Defining a RNA repair system conserved in pathogenic bacteria
$187,500Anna C. Karls · University Of Georgia · R21 · FY2016 · AI
Understanding HIV's impact on RR/MDR-TB development and transmission through genomics
$187,485Tara Catherine Bouton · Boston Medical Center · K23 · FY2022 · AI
Immunology Training Program-Predoctoral
$187,448Brian A Cobb · Case Western Reserve University · T32 · FY2016 · AI
Structure, Function and Applications of Inteins
$187,399Tom W Muir · Rockefeller University · R01 · FY2010 · GM
Mouse models for TB infection across the lifespan
$187,396Nancy R Manley · University Of Georgia · R21 · FY2015 · AI
MONOCYTE RECRUITMENT IN PLEURO PULMONARY TB IN AIDS
$187,396Indiana Univ-Purdue Univ At Indianapolis · R01 · FY2000 · AI
siRNA-nanoparticles host targeted immunotherapy for tuberculosis
$187,395Mercedes Gonzalez-Juarrero · Colorado State University · R21 · FY2015 · AI
A New Target for Anti-tuberculosis Agents, FAS 1
$187,375State University Of New York At Albany · R21 · FY2003 · AI
Dissecting the molecular regulation of T cell localization and function within the Mycobacterium tuberculosis granuloma
$187,356Benjamin Henry Gern · Seattle Children'S Hospital · K08 · FY2022 · AI
Non-invasive Fluorescent Imaging Mycobacterium tuberculosis Extrapulmonary Infect
$187,343Ying Kong · University Of Tennessee Health Sci Ctr · R21 · FY2013 · HL
Alternative functions for gamma delta T cells in the immune response to Mycobacterium
$187,216Jodi L. McGill · University Of Kansas Lawrence · P20 · FY2018 · GM
Orthogonal Approaches to Understanding the Role of PASTA Kinases in beta-lactam Resistance
$187,150John-Demian Sauer · University Of Wisconsin-Madison · R21 · FY2020 · AI
Dual mechanism thiopeptide analogs for TB drug development
$187,142Miriam S. Braunstein · Univ Of North Carolina Chapel Hill · R21 · FY2018 · AI
The role of the gut microbiome in susceptibility to Mycobacterium tuberculosis
$187,120Ashley Robin Wolf · University Of California Berkeley · R21 · FY2023 · AI
Research Training on Intracellular Pathogens
$187,093Kenneth D Stuart · Seattle Biomedical Research Institute · D43 · FY2010 · TW
Optimization of novel inhibitors of mycolic acid synthesis as TB drug candidates.
$187,091Kyle H Rohde · University Of Central Florida · R21 · FY2025 · AI
Evaluation of novel tuberculosis LAM assays among people living with HIV and sepsis
$187,055Tania A Thomas · University Of Virginia · R21 · FY2023 · AI
Sequencing and Epigenetics Core
$187,043Gregory Seumois · La Jolla Institute For Immunology · U19 · FY2023 · AI
Training in HIV Translational Research
$187,036Diane V Havlir · University Of California, San Francisco · T32 · FY2010 · AI
Immune Modulation During Acute Lyme Disease Infection as the Result of Aberrant Immunoglobulin Glycosylation
$187,033Mary Ann Comunale · Drexel University · R21 · FY2024 · AI
Gyrase B Inhibitors for Mycobacterium Tuberculosis
$187,023Peter B Madrid · Sri International · R21 · FY2013 · AI